Explore the latest developments concerning Kimberly-Clark to acquire.
Kimberly-Clark to acquire Kenvue in $48.7 billion deal
Kimberly-Clark said on Monday it will acquire Tylenol-maker Kenvue in a deal valued at about $48.7 billion, creating a consumer goods giant.
Kenvue's shares were up 18% in premarket trading. Kimberly-Clark said it would buy all of the outstanding shares of Kenvue common stock in a cash-and-stock transaction.
Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
That implies a per-share deal value of $21.01, or an equity value of $40.32 billion, according to Reuters calculations.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Will Provide Preferred Solutions Through Every Stage of Life
Applies Kimberly-Clark's Proven Commercial Execution Playbook to Create a Best-in-Class Consumer-Driven Company
Accelerates Kenvue's Premier Consumer Health Portfolio and Strong Science-Backed Innovation, Supported by Talented Kenvue Team
Enhances Investment in Marketing, Innovation and R&D Capabilities to Strengthen Combined Company's Unique Advantages
Total Anticipated Run-Rate Synergies of $2.1 Billion; Expected to Be Accretive to Kimberly-Clark's Adjusted EPS By Year 2
Delivers Immediate Upfront Value to Kenvue Shareholders, with Opportunity to Participate in Significant Future Upside from Combined Value Creation
Companies to Host Joint Investor Conference Call Today at 8:00 AM ET
BioloMix Cold Press Juicer,with 130mm Feed Chute,Fit Whole Fruits & Vegetables,High Juice Yield,BPA FREE Slow Masticating Juicer
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.